https://www.selleckchem.com/products/pds-0330.html
2). Moreover, the mean RV/LV ratio (mean difference -0.23, 95%CI -0.39 to -0.07) and the prevalence of RV/LV ratio 1.0 (prevalence difference -23%, 95%CI -41 to -0.86%) were lower in the COVID-19 patients. Conclusion Our findings therefore suggest that the phenotype of COVID-19 associated PE indeed differs from PE in patients without COVID-19, fuelling the discussion on its pathophysiology.Introduction Risk factors contributing to heightened thrombosis in pediatric congenital heart disease (CHD) patients are not fully understood. A
Like
Comment
Share
